---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-060589"
form_type: "8-K"
ticker: "INGN"
cik: "0001294133"
company_name: "Inogen Inc"
filed_at: "2024-05-15T23:59:59+00:00"
generated_at: "2026-06-01T22:45:36.634351+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Inogen CMO Stanislav Glezer departs; severance includes 12-month salary & COBRA

## Summary
- Dr. Stanislav Glezer separated as EVP R&D and Chief Medical Officer effective April 11, 2024.
- Severance: 12 months base salary of $505,000 (26 pay periods) and COBRA premium reimbursement for 12 months.
- Unvested equity awards forfeited; vested stock options remain exercisable per plan terms.
- No annual bonus owed; tuition repayment for CEO program waived.
- Separation agreement includes standard release of claims and confidentiality obligations.

## SEC filing metadata
- accession: 0000950170-24-060589
- form_type: 8-K
- ticker: INGN
- cik: 0001294133
- company_name: Inogen Inc
- filed_at: 2024-05-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1294133/000095017024060589/0000950170-24-060589-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1294133/000095017024060589/ingn-20240510.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-060589
- JSON: https://secwatch.observer/filing/0000950170-24-060589.json
- Plain text: https://secwatch.observer/filing/0000950170-24-060589.txt

## Key facts
- Executive change
  Stanislav Glezer departed as Executive Vice President, R&D and Chief Medical Officer at Inogen Inc.
  - Action: separated
  - Role: Executive Vice President, R&D and Chief Medical Officer
  source text: Dr. Glezer’s role as an officer and employee of the Company ended effective April 11, 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/1294133/000095017024060589/0000950170-24-060589-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.